Happy New Year!

The year 2017 is the year of the red rooster in the Chinese horoscope. Like a rooster greeting a new day, *Investigative and Clinical Urology* (ICUrology) will continue to take innovative steps towards becoming a top international journal after its successful launch in January 2016 in succession from the *Korean Journal of Urology* \[[@B1]\]. ICUrology aims to cover state-of-the-art research, both basic and clinical, that will have an impact on our understanding of various urological diseases and improve health care worldwide. ICUrology is currently indexed in MEDLINE/PubMed, PubMed Central (PMC), Emerging Sources Citation Index (ESCI), Scopus, Embase, and EBSCO.

In 2016, ICUrology published 6 regular issues bimonthly and 2 supplementary issues. Many outstanding papers were published in both investigative and clinical urology. Manuscripts were submitted from 33 countries, including Afghanistan, Albania, Austria, Brazil, Colombia, Indonesia, Israel, Jordan, Malaysia, Russian Federation, Spain, Pakistan, Thailand, and Tunisia. Accepted manuscripts came from Korea (39.5%), USA (23.7%), Australia (7.9%), Japan (7.9%), Turkey (5.3%), Canada (3.9%), Iran (2.6%), and Germany, India, Nepal, Hong Kong, Switzerland, China, and Singapore (1.3%), respectively. The acceptance rate of an original article and innovative surgical technique was 32.8% and 31.8%, respectively. The mean time from submission to the final decision in 2016 was 39 days, and the mean time from acceptance to online publication was 32 days. Thus, it is clear that ICUrology delivers timely knowledge to the international readers.

In 2016, we published 2 supplementary issues. The first special issue published in June focused on urothelial bladder cancer, which is a leading cause of cancer-related death in the field of urology \[[@B2]\]. We invited professor Wun-Jae Kim from Chungbuk National University Hospital, Korea, as a guest editor. Ten outstanding international scholars participated in this special issue, including professor Yoshihiko Hirao from Nara Medical University, Japan; professor Alexandre R. Zlotta from Mount Sinai Hospital, Canada; and professor Christopher P. Evans from UC Davis, USA. The title of the special issue was "Changing landscape of diagnosis and treatment of bladder cancer," which addressed the latest issues in the diagnosis and treatment of bladder cancer.

The second special issue was published in December and focused on robotic surgery, which aimed to provide evidence-based advancements in robotic surgery towards a standardized procedure \[[@B3]\]. Professor Koon Ho Rha from Yonsei University, Korea, thankfully served as a guest editor. The main theme was "Robotic surgery as an evolution of future direction." Eight outstanding international scholars participated in this special issue, including professor Masato Fujisawa from Kobe University, Japan, and professor John W. Davis from MD Anderson Cancer Center, USA.

In 2017, we again plan to publish 2 supplementary issues. The first will be hosted by professor Sang Won Han from Yonsei University, Korea, for the field of pediatric urology, and the second will be hosted by professor Kyu-Sung Lee from Sungkyunkwan University, Korea, in the field of voiding dysfunction.

In 2016, the editorial board of ICUrology held several meetings and workshops. The first International Editorial Board meeting was held in San Diego, USA, on May 8 during the AUA meeting after changing the name from the *Korean Journal of Urology*. Two workshops were also held for editorial board members and reviewers. The first workshop was held April 23 during the Korean Urological Congress & Expo in Gwangju, Korea. Professor Jong Woo Bae gave a lecture on "Publication ethics." The second workshop was held on October 14 during the 68th Annual Meeting of the Korean Urological Association in Seoul, Korea. As an invited speaker, professor Prokar Dasgupta, Editor-in-Chief of *BJU International* (BJUI), gave a talk on "How to design and publish the best systematic reviews." He also emphasized the mutual collaboration between BJUI and ICUrology.

In 2017, the editorial board of ICUrology is planning to expand our international leadership. To accept international research papers, we will invite more international editors and reviewers from around the world. We will keep the policy of open access publication with rapid review and early publication. ICUrology welcomes high-quality research and innovative studies in both investigative and clinical urology.

The editorial team of ICUrology will do our best to promote ICUrology as one of the premier journals in the field of urology.
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